Likely at least in part because there have been so many approved in a relatively short amount of time, we dont exactly know what the best approach is for using them
People with active cancers, severe liver conditions, cardiovascular diseases, or those who are pregnant or breastfeeding should avoid this treatment, at least until more research confirms its safety for these groups
Participants lost an average of 11.5% of body weight after just 26 weeks
Others argue that as long as high-cost drugs exist, utilization management (UM) is necessary, and ePA is the ethical approach to implement UM transparently and fairly
The combination therapys pharmacokinetic characteristics not only hold promise for efficacy and safety but also provide valuable insights into dosage optimization
**The Crucial Role of Your US Healthcare Provider:** * **Open Communication:** **Report ALL side effects** you experience to your doctor or provider, including their severity and when they occur